Concepedia

Carl W. Sigel

CW

Statistics

Publications

33

Citations

2K

H-Index

23

Active since

1963

Affiliations

Burroughs Wellcome Fund(Current)

Research Triangle Park Foundation

Triangle

Carl W. Sigel is an author at Burroughs Wellcome Fund specializing in pharmacology, pharmacy, and medicinal chemistry.

Publications per year

1963–1993

33

Publications

33

Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine

E. M. GRIVSKY, Shuliang Lee, Carl W. Sigel et al. · Journal of Medicinal Chemistry · 1980 · 359 citations

, , +8

Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica

S. Morris Kupchan, Ronald W. Britton, Myra F. Ziegler et al. · The Journal of Organic Chemistry · 1973 · 268 citations

, , +5

Tumor inhibitors. 100. Isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica

S. Morris Kupchan, Ronald W. Britton, John A. Lacadie et al. · The Journal of Organic Chemistry · 1975 · 164 citations

, , +8

Jatrophone, a novel macrocyclic diterpenoid tumor inhibitor from Jatropha gossypiifolia

S. Morris Kupchan, Carl W. Sigel, M Matz et al. · Journal of the American Chemical Society · 1970 · 146 citations

, , +9

Tumor inhibitors. 111. Structure and stereochemistry of jatrophone, a novel macrocyclic diterpenoid tumor inhibitor

S. Morris Kupchan, Carl W. Sigel, M Matz et al. · Journal of the American Chemical Society · 1976 · 106 citations

, , +10

1–5 of 33